Lisa Suennen
Showing 1–2 of 2 transcripts.
- Milken Institute1h 0m
Regulating Medical Innovation in the Digital Age
Lisa Suennen, William Carson, Aneesh Chopra, Sohini Chowdhury, Lucia Savage, Jeffrey Shuren, Lisa Sunin, Jeff Sheeran, Bill Carson
A panel of industry leaders and FDA officials analyzed the surge in digital healthcare investment, which has exceeded $40 billion, while addressing regulatory hurdles that slow the development of Software as a Medical Device. Key discussions highlighted the FDA's "Pre-Cert" pilot program and the critical need for interoperability standards like FHIR to reduce data costs and overcome fragmentation in telemedicine and direct-to-consumer markets. Despite breakthroughs such as the first digital medicine approval, experts emphasized that legacy frameworks struggle to accommodate rapid software iteration, opaque deep learning algorithms, and complex data privacy requirements across 57 state and federal jurisdictions.
- Milken Institute1h 3m
The Search for Cures Leads to Silicon Valley
Lindy Fishburne, Linda Avey, Noah Craft, Lloyd Minor, Asha Nayak, Lisa Suennen, Asha Rogers, Martha Minow, Male Speaker 2, Brody
Hosted by Lindy Fishburne, a panel of leaders from Intel, Stanford Medicine, 23andMe, and Science 37 discussed the strategic shift from reactive sick care to proactive precision health through decentralized data models and consumer engagement. Initiatives such as Intel's Collaborative Cancer Cloud, Stanford's genomic-phenotypic integration, and Science 37's patient-centric trials aim to dismantle data silos while accelerating drug discovery and increasing trial diversity. The dialogue further emphasized that sustainable innovation requires overcoming reimbursement barriers and establishing patient data sovereignty to enable real-world evidence generation.